These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2162347)
21. Phosphorylation by protein kinase C inactivates an inositol 1,4,5-trisphosphate 3-kinase purified from human platelets. Lin AN; Barnes S; Wallace RW Biochem Biophys Res Commun; 1990 Aug; 170(3):1371-6. PubMed ID: 2167676 [TBL] [Abstract][Full Text] [Related]
22. The metabolism of tris- and tetraphosphates of inositol by 5-phosphomonoesterase and 3-kinase enzymes. Connolly TM; Bansal VS; Bross TE; Irvine RF; Majerus PW J Biol Chem; 1987 Feb; 262(5):2146-9. PubMed ID: 3029066 [TBL] [Abstract][Full Text] [Related]
23. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor. Safrany ST; Sawyer DA; Nahorski SR; Potter BV Chirality; 1992; 4(7):415-22. PubMed ID: 1334423 [TBL] [Abstract][Full Text] [Related]
24. Inositol 1,3,4-trisphosphate acts in vivo as a specific regulator of cellular signaling by inositol 3,4,5,6-tetrakisphosphate. Yang X; Rudolf M; Carew MA; Yoshida M; Nerreter V; Riley AM; Chung SK; Bruzik KS; Potter BV; Schultz C; Shears SB J Biol Chem; 1999 Jul; 274(27):18973-80. PubMed ID: 10383396 [TBL] [Abstract][Full Text] [Related]
25. Ca2+ regulates the inositol tris/tetrakisphosphate pathway in intact and broken preparations of insulin-secreting RINm5F cells. Biden TJ; Wollheim CB J Biol Chem; 1986 Sep; 261(26):11931-4. PubMed ID: 3017952 [TBL] [Abstract][Full Text] [Related]
26. Interaction of the catalytic domain of inositol 1,4,5-trisphosphate 3-kinase A with inositol phosphate analogues. Poinas A; Backers K; Riley AM; Mills SJ; Moreau C; Potter BV; Erneux C Chembiochem; 2005 Aug; 6(8):1449-57. PubMed ID: 15997461 [TBL] [Abstract][Full Text] [Related]
27. Metabolism of D-myo-inositol 1,3,4,5-tetrakisphosphate by rat liver, including the synthesis of a novel isomer of myo-inositol tetrakisphosphate. Shears SB; Parry JB; Tang EK; Irvine RF; Michell RH; Kirk CJ Biochem J; 1987 Aug; 246(1):139-47. PubMed ID: 2823793 [TBL] [Abstract][Full Text] [Related]
28. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities. Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885 [TBL] [Abstract][Full Text] [Related]
29. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate. Hirata M; Narumoto N; Watanabe Y; Kanematsu T; Koga T; Ozaki S Mol Pharmacol; 1994 Feb; 45(2):271-6. PubMed ID: 8114676 [TBL] [Abstract][Full Text] [Related]
31. Ca2(+)-stimulatable and protein kinase C-inhibitable accumulation of inositol 1,3,4,6-tetrakisphosphate in human platelets. King WG; Downes CP; Prestwich GD; Rittenhouse SE Biochem J; 1990 Aug; 270(1):125-31. PubMed ID: 2396972 [TBL] [Abstract][Full Text] [Related]
32. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors. Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354 [TBL] [Abstract][Full Text] [Related]
33. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor. Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms involved in receptor-mediated changes of intracellular Ca2+ in liver. Williamson JR; Hansen CA; Verhoeven A; Coll KE; Johanson R; Williamson MT; Filburn C Soc Gen Physiol Ser; 1987; 42():93-116. PubMed ID: 2850613 [TBL] [Abstract][Full Text] [Related]
35. Prostaglandin F2 alpha stimulates inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate formation in bovine luteal cells. Duncan RA; Davis JS Endocrinology; 1991 Mar; 128(3):1519-26. PubMed ID: 1847860 [TBL] [Abstract][Full Text] [Related]
36. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase. Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077 [TBL] [Abstract][Full Text] [Related]
37. 3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition. Safrany ST; Wilcox RA; Liu C; Potter BV; Nahorski SR Eur J Pharmacol; 1992 Jul; 226(3):265-72. PubMed ID: 1330634 [TBL] [Abstract][Full Text] [Related]
38. Molecular study and regulation of D-myo-inositol 1,4,5-trisphosphate 3-kinase. Communi D; Vanweyenberg V; Erneux C Cell Signal; 1995 Sep; 7(7):643-50. PubMed ID: 8519593 [TBL] [Abstract][Full Text] [Related]